PHYTOPHARM
LIVE

Serial Number

79111855

Owner

Phytopharm Plc

Attorney

Mark B. Harrison

Filing Date

Oct 13, 2011

Add to watchlist:

No watchlists yet
View on USPTO

PHYTOPHARM Trademark

Serial Number: 79111855 • Registration: 4434306

PHYTOPHARM is a trademark filed by Phytopharm Plc on October 13, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Phytopharm Plc (8 trademarks)

Corpus Christi House
Godmanchester, Cambridgeshire PE29 2HY , GB

Entity Type: 03

Trademark Details

Filing Date

October 13, 2011

Registration Date

November 19, 2013

Published for Opposition

September 3, 2013

Cancellation Date

October 13, 2021

Goods & Services

Pharmaceutical and veterinary preparations for treating neurodegenerative diseases, ophthalmological disorders and diseases, central nervous system disorders and diseases, and inflammatory disease; pharmaceutical preparations for the treatment of infectious diseases, and diseases and disorders in the field of, oncology, hepatology, nephrology, cardiovascular, vascular, respiratory, serology, immunology, hematology, metabolism, neurology and neurodegeneration, neuropathies, pain, gastrointestinal, dermatology, muscoskeletal, central nervous system, endocrinology, hormonal, psychiatric, dementia, urology, obstetrics and gynaecology, ophthalmology, inflammation, odontology, dentistry, cognition, genetic disorders, cerebrovascular, eating disorders, hearing, hypothalamic and pituitary diseases, and sleep disorders

Chemicals used in industry and science; chemicals for use in the manufacture of medical and veterinary products; chemicals being artificial plant extracts for use in industry and science

Medical services; veterinary services; medical analysis for the diagnosis and treatment of persons; veterinary analysis for the diagnosis and treatment of animals and birds; medical and veterinary consulting services in the field of pharmaceutical and veterinary products; medical and veterinary consulting services in the field of plant extracts for pharmaceutical and veterinary use; clinical diagnostic services, namely, investigation in the nature of diagnosis, analysis, testing and monitoring of patients for the purpose of identification and characterization of patients before, during and after therapy or treatment

Scientific and technological services and research and design relating thereto, namely, medical research, chemistry research, biochemistry research, pharmaceutical research; research and development of pharmaceuticals and veterinary preparations and products; biological, biochemical and chemistry research services; drug discovery services; medical and scientific research, namely, conducting clinical trials for others; preclinical services, namely, scientific research services in the nature of characterization, optimization, profiling of efficacy, toxicity and therapeutic effect of drugs and scientific research analysis, testing and monitoring of biological and chemical material in the area of identification and characterization of medical and veterinary conditions, illnesses and diseases; scientific research and consultancy services in the fields of preclinical and clinical trials for pharmaceuticals and veterinary preparations and products; medical and veterinary research services

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
May 8, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
May 8, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jan 22, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 20, 2021 INTS
INVALIDATION PROCESSED
Dec 20, 2021 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 6, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 19, 2014 FICS
FINAL DISPOSITION PROCESSED
Feb 19, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 19, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 19, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Sep 15, 2013 GPNX
PUBLISHED FOR OPPOSITION
Sep 3, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 28, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 28, 2013 OP2R
NOTICE OF PUBLICATION
Aug 14, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 30, 2013 PREV
EXAMINERS AMENDMENT MAILED
Jul 25, 2013 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 25, 2013 XAEC
EXAMINERS AMENDMENT -WRITTEN
Jul 25, 2013 CNEA
FINAL REFUSAL MAILED
Dec 27, 2012 CNFR
FINAL REFUSAL WRITTEN
Dec 27, 2012 CNFR
AMENDMENT FROM APPLICANT ENTERED
Nov 30, 2012 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2012 CRFA
ASSIGNED TO LIE
Nov 20, 2012 ALIE
PAPER RECEIVED
Nov 14, 2012 MAIL
REFUSAL PROCESSED BY IB
Jun 7, 2012 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 15, 2012 RFCS
REFUSAL PROCESSED BY MPU
May 15, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 12, 2012 RFCR
NON-FINAL ACTION WRITTEN
May 11, 2012 CNRT
APPLICATION FILING RECEIPT MAILED
May 8, 2012 MAFR
ASSIGNED TO EXAMINER
May 4, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 4, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 3, 2012 REPR